Andrew Kucharchuk
Director of Finance/CFO at THERALINK TECHNOLOGIES, INC.
Net worth: 290 $ as of 2024-03-30
Profile
Andrew Albert Kucharchuk occupies the position of Chairman & Chief Executive Officer at Adhera Therapeutics, Inc. He is also on the board of Theralink Technologies, Inc. (Colorado), OncBioMune, Inc. and Theralink Technologies, Inc. (former Chief Financial Officer & Director) and Member of Kappa Alpha Order. Mr. Kucharchuk received an undergraduate degree from Louisiana State University and an MBA from A.B. Freeman School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2022-12-28 | 290,000 ( 0.00% ) | 290 $ | 2024-03-30 |
Andrew Kucharchuk active positions
| Companies | Position | Start |
|---|---|---|
| THERALINK TECHNOLOGIES, INC. | Director of Finance/CFO | 2023-05-07 |
| AVANT DIAGNOSTICS INC | Director/Board Member | - |
| ADHERA THERAPEUTICS, INC. | Chief Operating Officer | 2022-09-29 |
| CHAIN BRIDGE I | Director of Finance/CFO | 2024-03-31 |
| Kappa Alpha Order | Corporate Officer/Principal | - |
Former positions of Andrew Kucharchuk
| Companies | Position | End |
|---|---|---|
OncBioMune, Inc.
 OncBioMune, Inc. BiotechnologyHealth Technology OncBioMune, Inc. develops biotechnologies for cancer treatment. The company is headquartered in Baton Rouge, LA. | Chief Executive Officer | - |
Training of Andrew Kucharchuk
| Louisiana State University | Undergraduate Degree |
| A.B. Freeman School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| THERALINK TECHNOLOGIES, INC. | Health Technology |
| CHAIN BRIDGE I | Finance |
| ADHERA THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Kappa Alpha Order | |
OncBioMune, Inc.
OncBioMune, Inc. BiotechnologyHealth Technology OncBioMune, Inc. develops biotechnologies for cancer treatment. The company is headquartered in Baton Rouge, LA. | Health Technology |
Theralink Technologies, Inc. (Colorado)
 Theralink Technologies, Inc. (Colorado) Medical SpecialtiesHealth Technology Theralink Technologies, Inc. engages in the provision of biomarker assay services in the areas of oncology. The firm offers personalized medicine data through TheraLink assays to assist the biopharmaceutical industry and clinical oncologists in identifying drug treatments. It develops phosphoproteomic technologies that measure the activation status of signaling pathways. The company was founded on October 16, 2008 and is headquartered in Golden, CO. | Health Technology |
- Stock Market
- Insiders
- Andrew Kucharchuk
